Generation of inducible hepatitis C virus transgenic mouse lines

Journal of Medical Virology

Volumn 79, Issue 8, 2007, Pages 1103-1112

  Ernst, Evelyn ^a   Schönig, Kai ^a   Bugert, Joachim J ^b   Bläker, Hendrik ^a   Pfaff, Eberhard ^c   Stremmel, Wolfgang ^a   Encke, Jens ^a,d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^d Universitiy of Heidelberg ^*  (Germany)

Author keywords

HCV transgenic mouse; Liver pathology; Long term induction; Tet on system

Indexed keywords

AMINOTRANSFERASE; LUCIFERASE; VIRUS PROTEIN;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CONTROLLED STUDY; FATTY LIVER; FEMALE; HEART; HEPATITIS C VIRUS; IMMUNOPATHOLOGY; IMMUNOPRECIPITATION; KIDNEY; LIVER; MALE; MOUSE; NONHUMAN; OPEN READING FRAME; PROTEIN EXPRESSION; SPLEEN; TISSUE DISTRIBUTION; TRANSGENE; TRANSGENIC MOUSE; VIRUS CORE; VIRUS EXPRESSION; VIRUS PATHOGENESIS; WESTERN BLOTTING;

ALANINE TRANSAMINASE; ANIMALS; DOXYCYCLINE; FEMALE; GENE EXPRESSION REGULATION; HEPACIVIRUS; LIVER; LUCIFERASES; MALE; MICE; MICE, TRANSGENIC; SPLEEN; VIRAL NONSTRUCTURAL PROTEINS;

ANIMALIA; HEPATITIS C VIRUS; MUS; MUS MUSCULUS;

EID: 34347323899     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20911     Document Type: Article

References (36)

1. Alonzi T, Agrati C, Costabile B, Cicchini C, Amicone L, Cavallari C, Rocca CD, Folgori A, Fipaldini C, Poccia F, Monica NL, Tripodi M. 2004. Steatosis and intrahepatic lymphocyte recruitment in hepatitis C virus transgenic mice. J Gen Virol 85:1509-1520.
2. Baron U, Freundlieb S, Gossen M, Bujard H. 1995. Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res 23:3605-3606.
3. Blasco R, Moss B. 1995. Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 158:157-162.
4. Blindenbacher A, Duong FH, Hunziker L, Stutvoet ST, Wang X, Terracciano L, Moradpour D, Blum HE, Alonzi T, Tripodi M, La Monica N, Heim MH. 2003. Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice. Gastroenterology 124:1465-1475.
5. Costantini F, Radice G, Lee JL, Chada KK, Perry W, Son HJ. 1989. Insertional mutations in transgenic mice. Prog Nucleic Acid Res Mol Biol 36:159-169.
6. Disson O, Haouzi D, Desagher S, Loesch K, Hahne M, Kremer EJ, Jacquet C, Lemon SM, Hibner U, Lerat H. 2004. Impaired clearance of virus-infected hepatocytes in transgenic mice expressing the hepatitis C virus polyprotein. Gastroenterology 126:859-872.
7. Encke J, zu Putlitz J, Stremmel W, Wands JR. 2003. CpG immunostimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization. Arch Virol 148:435-448.
8. Estcourt MJ, Ramsay AJ, Brooks A, Thomson SA, Medveckzy CJ, Ramshaw IA. 2002. Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population. Int Immunol 14:31-37.
9. Gossen M, Bujard H. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547-5551.
10. Hammes A SA. 2000. Generation of transgenic mice from plasmids, BACs and YACs. Jackson IJ AC, editor. New York: Oxford University Press, pp 217-245.
11. Hasan MT, Schonig K, Berger S, Graewe W, Bujard H. 2001. Long-term, noninvasive imaging of regulated gene expression in living mice. Genesis 29:116-122.
12. Kato T, Ahmed M, Yamamoto T, Takahashi H, Oohara M, Ikeda T, Aida Y, Katsuki M, Arakawa Y, Shikata T, Esumi M. 1996. Inactivation of hepatitis C virus cDNA transgene by hypermethylation in transgenic mice. Arch Virol 141:951-958.
13. Kato T, Miyamoto M, Date T, Yasui K, Taya C, Yonekawa H, Ohue C, Yagi S, Seki E, Hirano T, Fujimoto J, Shirai T, Wakita T. 2003. Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice. Cancer Sci 94:679-685.
14. Kawamura T, Furusaka A, Koziel MJ, Chung RT, Wang TC, Schmidt EV, Liang TJ. 1997. Transgenic expression of hepatitis C virus structural proteins in the mouse. Hepatology 25:1014-1021.
15. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lubbert H, Bujard H. 1996. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 93:10933-10938.
16. Koike K, Moriya K, Kimura S. 2002. Role of hepatitis C virus in the development of hepatocellular carcinoma: Transgenic approach to viral hepatocarcinogenesis. J Gastroenterol Hepatol 17:394-400.
17. Lanford RE, Bigger C. 2002. Advances in model systems for hepatitis C virus research. Virology 293:1-9.
18. Lerat H, Honda M, Beard MR, Loesch K, Sun J, Yang Y, Okuda M, Gosert R, Xiao SY, Weinman SA, Lemon SM. 2002. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterol 122:352-365.
19. Matsuda J, Suzuki M, Nozaki C, Shinya N, Tashiro K, Mizuno K, Uchinuno Y, Yamamura K. 1998. Transgenic mouse expressing a full-length hepatitis C virus cDNA. Jpn J Cancer Res 89:150-158.
20. Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, Matsuura Y, Miyamura T, Koike K. 1997. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 78:1527-1531.
21. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K. 1998. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4:1065-1067.
22. Moriya K, Nakagawa K, Santa T, Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Miyazawa T, Ishibashi K, Horie T, Imai K, Todoroki T, Kimura S, Koike K. 2001. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 61:4365-4370.
23. Pasquinelli C, Shoenberger JM, Chung J, Chang KM, Guidotti LG, Selby M, Berger K, Lesniewski R, Houghton M, Chisari FV. 1997. Hepatitis C virus core and E2 protein expression in transgenic mice. Hepatology 25:719-727.
24. Perlemuter G, Letteron P, Carnot F, Zavala F, Pessayre D, Nalpas B, Brechot C. 2003. Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model. J Hepatol 39:1020-1027.
25. Ramshaw IA, Ramsay AJ. 2000. The prime-boost strategy: Exciting prospects for improved vaccination. Immunol Today 21:163-165.
26. Saito T, Sherman GJ, Kurokohchi K, Guo ZP, Donets M, Yu MY, Berzofsky JA, Akatsuka T, Feinstone SM. 1997. Plasmid DNA-based immunization for hepatitis C virus structural proteins: Immune responses in mice. Gastroenterol 112:1321-1330.
27. Schonig K, Bujard H. 2003. Generating conditional mouse mutants via tetracycline-controlled gene expression. Methods Mol Biol 209:69-104.
28. Schonig K, Schwenk F, Rajewsky K, Bujard H. 2002. Stringent doxycycline dependent control of CRE recombinase in vivo. Nucleic Acids Res 30:e134.
29. Talbot D, Descombes P, Schibler U. 1994. The 5′ flanking region of the rat LAP (C/EBP beta) gene can direct high-level, position-independent, copy number-dependent expression in multiple tissues in transgenic mice. Nucleic Acids Res 22:756-766.
30. Tokushige K, Wakita T, Pachuk C, Moradpour D, Weiner DB, Zurawski VR, Jr., Wands JR. 1996. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs. Hepatology 24:14-20.
31. Tsutsumi T, Suzuki T, Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Matsuura Y, Kimura S, Koike K, Miyamura T. 2002. Alteration of intrahepatic cytokine expression and AP-1 activation in transgenic mice expressing hepatitis C virus core protein. Virology 304:415-424.
32. Tsutsumi T, Suzuki T, Moriya K, Shintani Y, Fujie H, Miyoshi H, Matsuura Y, Koike K, Miyamura T. 2003. Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice. Hepatology 38:820-828.
33. Wakita T, Taya C, Katsume A, Kato J, Yonekawa H, Kanegae Y, Saito I, Hayashi Y, Koike M, Kohara M. 1998. Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/loxP system. J Biol Chem 273:9001-9006.
34. Wakita T, Katsume A, Kato J, Taya C, Yonekawa H, Kanegae Y, Saito I, Hayashi Y, Koike M, Miyamoto M, Hiasa Y, Kohara M. 2000. Possible role of cytotoxic T cells in acute liver injury in hepatitis C virus cDNA transgenic mice mediated by Cre/loxP system. J Med Virol 62:308-317.
35. Yanagi M, Purcell RH, Emerson SU, Bukh J. 1997. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci USA 94:8738-8743.
36. Yu Z, Redfern CS, Fishman GI. 1996. Conditional transgene expression in the heart. Circ Res 79:691-697.